HEADER SIGNALING PROTEIN 04-JAN-16 5HCV TITLE IDENTIFICATION OF SPIROOXINDOLE AND DIBENZOXAZEPINE MOTIFS AS POTENT TITLE 2 MINERALOCORTICOID RECEPTOR ANTAGONISTS COMPND MOL_ID: 1; COMPND 2 MOLECULE: MINERALOCORTICOID RECEPTOR; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: LIGAND-BINDING DOMAIN (UNP RESIDUES 732-984); COMPND 5 SYNONYM: MR,NUCLEAR RECEPTOR SUBFAMILY 3 GROUP C MEMBER 2; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR3C2, MCR, MLR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PMAL_C5X KEYWDS MINERALOCORTICOID RECEPTOR, LIGAND-BINDING DOMAIN, MR-LBD, KEYWDS 2 ANTAGONISTS, CO-CRYSTAL, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR G.CHEN,B.M.MCKEEVER REVDAT 3 27-SEP-23 5HCV 1 REMARK REVDAT 2 09-AUG-17 5HCV 1 REMARK REVDAT 1 09-MAR-16 5HCV 0 JRNL AUTH S.D.LOTESTA,A.P.MARCUS,Y.ZHENG,K.LEFTHERIS,P.B.NOTO,S.MENG, JRNL AUTH 2 G.KANDPAL,G.CHEN,J.ZHOU,B.MCKEEVER,Y.BUKHTIYAROV,Y.ZHAO, JRNL AUTH 3 D.S.LALA,S.B.SINGH,G.M.MCGEEHAN JRNL TITL IDENTIFICATION OF SPIROOXINDOLE AND DIBENZOXAZEPINE MOTIFS JRNL TITL 2 AS POTENT MINERALOCORTICOID RECEPTOR ANTAGONISTS. JRNL REF BIOORG.MED.CHEM. V. 24 1384 2016 JRNL REFN ESSN 1464-3391 JRNL PMID 26897089 JRNL DOI 10.1016/J.BMC.2016.02.014 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0071 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.41 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 24098 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.174 REMARK 3 R VALUE (WORKING SET) : 0.170 REMARK 3 FREE R VALUE : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1292 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.56 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1777 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.79 REMARK 3 BIN R VALUE (WORKING SET) : 0.2180 REMARK 3 BIN FREE R VALUE SET COUNT : 87 REMARK 3 BIN FREE R VALUE : 0.3160 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5744 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 85 REMARK 3 SOLVENT ATOMS : 260 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 50.71 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.02000 REMARK 3 B22 (A**2) : -0.02000 REMARK 3 B33 (A**2) : 0.05000 REMARK 3 B12 (A**2) : -0.01000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.327 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.249 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 11.238 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.958 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.895 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5977 ; 0.012 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 8078 ; 1.609 ; 1.980 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 687 ; 5.583 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 271 ;37.887 ;24.576 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1084 ;18.092 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 21 ;16.646 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 883 ; 0.105 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4420 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2778 ; 3.490 ; 4.822 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3455 ; 5.167 ; 7.219 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3199 ; 4.865 ; 5.146 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 25959 ;10.362 ;45.837 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NCS TYPE: LOCAL REMARK 3 NUMBER OF DIFFERENT NCS PAIRS : 3 REMARK 3 GROUP CHAIN1 RANGE CHAIN2 RANGE COUNT RMS WEIGHT REMARK 3 1 A 738 982 B 738 982 302 0.16 0.05 REMARK 3 2 A 738 982 C 738 982 292 0.17 0.05 REMARK 3 3 B 738 982 C 738 982 297 0.16 0.05 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5HCV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-JAN-16. REMARK 100 THE DEPOSITION ID IS D_1000216671. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-APR-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 - 8.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X29A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.075 REMARK 200 MONOCHROMATOR : SAGITTALLY-FOCUSED MONOCHROMATOR REMARK 200 OPTICS : CRYOGENICALLY-COOLED REMARK 200 MONOCHROMATOR+VERTICAL FOCUSING REMARK 200 MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 701C3.DB027 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24098 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 44.410 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 10.90 REMARK 200 R MERGE (I) : 0.16500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.56 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 8.30 REMARK 200 R MERGE FOR SHELL (I) : 0.95000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 2A3I REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.53 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1UL OF PROTEIN COMPLEX AT 8-10MG REMARK 280 PROTEIN/ML IS MIXED WITH AN EQUAL VOLUME OF RESERVOIR SOLUTION REMARK 280 COMPOSED OF 100MM TRIS-HCL PH=8.0, 200MM NACL, 5% (V/V) GLYCEROL, REMARK 280 16%(W/V) PEG3350, PH 8.0, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 14.80200 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 29.60400 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 728 REMARK 465 SER A 729 REMARK 465 HIS A 730 REMARK 465 MET A 731 REMARK 465 ARG A 732 REMARK 465 ALA A 733 REMARK 465 LEU A 734 REMARK 465 THR A 735 REMARK 465 PRO A 736 REMARK 465 SER A 737 REMARK 465 ASP A 755 REMARK 465 SER A 756 REMARK 465 SER A 757 REMARK 465 LYS A 758 REMARK 465 THR A 908 REMARK 465 LYS A 909 REMARK 465 CYS A 910 REMARK 465 PRO A 911 REMARK 465 ASN A 912 REMARK 465 ARG A 983 REMARK 465 LYS A 984 REMARK 465 GLY B 728 REMARK 465 SER B 729 REMARK 465 HIS B 730 REMARK 465 MET B 731 REMARK 465 ARG B 732 REMARK 465 ALA B 733 REMARK 465 LEU B 734 REMARK 465 THR B 735 REMARK 465 PRO B 736 REMARK 465 SER B 737 REMARK 465 ASP B 755 REMARK 465 SER B 756 REMARK 465 SER B 757 REMARK 465 LYS B 758 REMARK 465 THR B 908 REMARK 465 LYS B 909 REMARK 465 CYS B 910 REMARK 465 PRO B 911 REMARK 465 ASN B 912 REMARK 465 ASN B 913 REMARK 465 SER B 914 REMARK 465 GLY B 915 REMARK 465 GLN B 916 REMARK 465 ARG B 983 REMARK 465 LYS B 984 REMARK 465 GLY C 728 REMARK 465 SER C 729 REMARK 465 HIS C 730 REMARK 465 MET C 731 REMARK 465 ARG C 732 REMARK 465 ALA C 733 REMARK 465 LEU C 734 REMARK 465 THR C 735 REMARK 465 PRO C 736 REMARK 465 SER C 737 REMARK 465 ASP C 755 REMARK 465 SER C 756 REMARK 465 SER C 757 REMARK 465 LYS C 758 REMARK 465 THR C 908 REMARK 465 LYS C 909 REMARK 465 CYS C 910 REMARK 465 PRO C 911 REMARK 465 ASN C 912 REMARK 465 ASN C 913 REMARK 465 SER C 914 REMARK 465 GLY C 915 REMARK 465 GLN C 916 REMARK 465 GLU C 972 REMARK 465 SER C 973 REMARK 465 GLY C 974 REMARK 465 ARG C 983 REMARK 465 LYS C 984 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN C 975 O HOH C 1101 2.09 REMARK 500 NH1 ARG A 947 OE1 GLU A 972 2.10 REMARK 500 NZ LYS A 887 O HOH A 1101 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 953 21.51 80.86 REMARK 500 ASN B 836 -168.59 -101.44 REMARK 500 SER B 973 10.55 -65.58 REMARK 500 ASN B 975 44.89 -105.65 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 60R A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 60R B 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL B 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 60R C 1001 DBREF 5HCV A 732 984 UNP P08235 MCR_HUMAN 732 984 DBREF 5HCV B 732 984 UNP P08235 MCR_HUMAN 732 984 DBREF 5HCV C 732 984 UNP P08235 MCR_HUMAN 732 984 SEQADV 5HCV GLY A 728 UNP P08235 EXPRESSION TAG SEQADV 5HCV SER A 729 UNP P08235 EXPRESSION TAG SEQADV 5HCV HIS A 730 UNP P08235 EXPRESSION TAG SEQADV 5HCV MET A 731 UNP P08235 EXPRESSION TAG SEQADV 5HCV SER A 808 UNP P08235 CYS 808 ENGINEERED MUTATION SEQADV 5HCV GLY B 728 UNP P08235 EXPRESSION TAG SEQADV 5HCV SER B 729 UNP P08235 EXPRESSION TAG SEQADV 5HCV HIS B 730 UNP P08235 EXPRESSION TAG SEQADV 5HCV MET B 731 UNP P08235 EXPRESSION TAG SEQADV 5HCV SER B 808 UNP P08235 CYS 808 ENGINEERED MUTATION SEQADV 5HCV GLY C 728 UNP P08235 EXPRESSION TAG SEQADV 5HCV SER C 729 UNP P08235 EXPRESSION TAG SEQADV 5HCV HIS C 730 UNP P08235 EXPRESSION TAG SEQADV 5HCV MET C 731 UNP P08235 EXPRESSION TAG SEQADV 5HCV SER C 808 UNP P08235 CYS 808 ENGINEERED MUTATION SEQRES 1 A 257 GLY SER HIS MET ARG ALA LEU THR PRO SER PRO VAL MET SEQRES 2 A 257 VAL LEU GLU ASN ILE GLU PRO GLU ILE VAL TYR ALA GLY SEQRES 3 A 257 TYR ASP SER SER LYS PRO ASP THR ALA GLU ASN LEU LEU SEQRES 4 A 257 SER THR LEU ASN ARG LEU ALA GLY LYS GLN MET ILE GLN SEQRES 5 A 257 VAL VAL LYS TRP ALA LYS VAL LEU PRO GLY PHE LYS ASN SEQRES 6 A 257 LEU PRO LEU GLU ASP GLN ILE THR LEU ILE GLN TYR SER SEQRES 7 A 257 TRP MET SER LEU SER SER PHE ALA LEU SER TRP ARG SER SEQRES 8 A 257 TYR LYS HIS THR ASN SER GLN PHE LEU TYR PHE ALA PRO SEQRES 9 A 257 ASP LEU VAL PHE ASN GLU GLU LYS MET HIS GLN SER ALA SEQRES 10 A 257 MET TYR GLU LEU CYS GLN GLY MET HIS GLN ILE SER LEU SEQRES 11 A 257 GLN PHE VAL ARG LEU GLN LEU THR PHE GLU GLU TYR THR SEQRES 12 A 257 ILE MET LYS VAL LEU LEU LEU LEU SER THR ILE PRO LYS SEQRES 13 A 257 ASP GLY LEU LYS SER GLN ALA ALA PHE GLU GLU MET ARG SEQRES 14 A 257 THR ASN TYR ILE LYS GLU LEU ARG LYS MET VAL THR LYS SEQRES 15 A 257 CYS PRO ASN ASN SER GLY GLN SER TRP GLN ARG PHE TYR SEQRES 16 A 257 GLN LEU THR LYS LEU LEU ASP SER MET HIS ASP LEU VAL SEQRES 17 A 257 SER ASP LEU LEU GLU PHE CYS PHE TYR THR PHE ARG GLU SEQRES 18 A 257 SER HIS ALA LEU LYS VAL GLU PHE PRO ALA MET LEU VAL SEQRES 19 A 257 GLU ILE ILE SER ASP GLN LEU PRO LYS VAL GLU SER GLY SEQRES 20 A 257 ASN ALA LYS PRO LEU TYR PHE HIS ARG LYS SEQRES 1 B 257 GLY SER HIS MET ARG ALA LEU THR PRO SER PRO VAL MET SEQRES 2 B 257 VAL LEU GLU ASN ILE GLU PRO GLU ILE VAL TYR ALA GLY SEQRES 3 B 257 TYR ASP SER SER LYS PRO ASP THR ALA GLU ASN LEU LEU SEQRES 4 B 257 SER THR LEU ASN ARG LEU ALA GLY LYS GLN MET ILE GLN SEQRES 5 B 257 VAL VAL LYS TRP ALA LYS VAL LEU PRO GLY PHE LYS ASN SEQRES 6 B 257 LEU PRO LEU GLU ASP GLN ILE THR LEU ILE GLN TYR SER SEQRES 7 B 257 TRP MET SER LEU SER SER PHE ALA LEU SER TRP ARG SER SEQRES 8 B 257 TYR LYS HIS THR ASN SER GLN PHE LEU TYR PHE ALA PRO SEQRES 9 B 257 ASP LEU VAL PHE ASN GLU GLU LYS MET HIS GLN SER ALA SEQRES 10 B 257 MET TYR GLU LEU CYS GLN GLY MET HIS GLN ILE SER LEU SEQRES 11 B 257 GLN PHE VAL ARG LEU GLN LEU THR PHE GLU GLU TYR THR SEQRES 12 B 257 ILE MET LYS VAL LEU LEU LEU LEU SER THR ILE PRO LYS SEQRES 13 B 257 ASP GLY LEU LYS SER GLN ALA ALA PHE GLU GLU MET ARG SEQRES 14 B 257 THR ASN TYR ILE LYS GLU LEU ARG LYS MET VAL THR LYS SEQRES 15 B 257 CYS PRO ASN ASN SER GLY GLN SER TRP GLN ARG PHE TYR SEQRES 16 B 257 GLN LEU THR LYS LEU LEU ASP SER MET HIS ASP LEU VAL SEQRES 17 B 257 SER ASP LEU LEU GLU PHE CYS PHE TYR THR PHE ARG GLU SEQRES 18 B 257 SER HIS ALA LEU LYS VAL GLU PHE PRO ALA MET LEU VAL SEQRES 19 B 257 GLU ILE ILE SER ASP GLN LEU PRO LYS VAL GLU SER GLY SEQRES 20 B 257 ASN ALA LYS PRO LEU TYR PHE HIS ARG LYS SEQRES 1 C 257 GLY SER HIS MET ARG ALA LEU THR PRO SER PRO VAL MET SEQRES 2 C 257 VAL LEU GLU ASN ILE GLU PRO GLU ILE VAL TYR ALA GLY SEQRES 3 C 257 TYR ASP SER SER LYS PRO ASP THR ALA GLU ASN LEU LEU SEQRES 4 C 257 SER THR LEU ASN ARG LEU ALA GLY LYS GLN MET ILE GLN SEQRES 5 C 257 VAL VAL LYS TRP ALA LYS VAL LEU PRO GLY PHE LYS ASN SEQRES 6 C 257 LEU PRO LEU GLU ASP GLN ILE THR LEU ILE GLN TYR SER SEQRES 7 C 257 TRP MET SER LEU SER SER PHE ALA LEU SER TRP ARG SER SEQRES 8 C 257 TYR LYS HIS THR ASN SER GLN PHE LEU TYR PHE ALA PRO SEQRES 9 C 257 ASP LEU VAL PHE ASN GLU GLU LYS MET HIS GLN SER ALA SEQRES 10 C 257 MET TYR GLU LEU CYS GLN GLY MET HIS GLN ILE SER LEU SEQRES 11 C 257 GLN PHE VAL ARG LEU GLN LEU THR PHE GLU GLU TYR THR SEQRES 12 C 257 ILE MET LYS VAL LEU LEU LEU LEU SER THR ILE PRO LYS SEQRES 13 C 257 ASP GLY LEU LYS SER GLN ALA ALA PHE GLU GLU MET ARG SEQRES 14 C 257 THR ASN TYR ILE LYS GLU LEU ARG LYS MET VAL THR LYS SEQRES 15 C 257 CYS PRO ASN ASN SER GLY GLN SER TRP GLN ARG PHE TYR SEQRES 16 C 257 GLN LEU THR LYS LEU LEU ASP SER MET HIS ASP LEU VAL SEQRES 17 C 257 SER ASP LEU LEU GLU PHE CYS PHE TYR THR PHE ARG GLU SEQRES 18 C 257 SER HIS ALA LEU LYS VAL GLU PHE PRO ALA MET LEU VAL SEQRES 19 C 257 GLU ILE ILE SER ASP GLN LEU PRO LYS VAL GLU SER GLY SEQRES 20 C 257 ASN ALA LYS PRO LEU TYR PHE HIS ARG LYS HET 60R A1001 28 HET 60R B1001 28 HET CL B1002 1 HET 60R C1001 28 HETNAM 60R 6-[(~{E})-(3-FLUORANYL-6~{H}-BENZO[C][1]BENZOXEPIN-11- HETNAM 2 60R YLIDENE)METHYL]-4~{H}-1,4-BENZOXAZIN-3-ONE HETNAM CL CHLORIDE ION FORMUL 4 60R 3(C23 H16 F N O3) FORMUL 6 CL CL 1- FORMUL 8 HOH *260(H2 O) HELIX 1 AA1 PRO A 738 ILE A 745 1 8 HELIX 2 AA2 THR A 761 VAL A 786 1 26 HELIX 3 AA3 GLY A 789 LEU A 793 5 5 HELIX 4 AA4 PRO A 794 SER A 805 1 12 HELIX 5 AA5 SER A 805 ASN A 823 1 19 HELIX 6 AA6 ASN A 836 ALA A 844 1 9 HELIX 7 AA7 MET A 845 GLN A 863 1 19 HELIX 8 AA8 THR A 865 LEU A 878 1 14 HELIX 9 AA9 SER A 888 VAL A 907 1 20 HELIX 10 AB1 SER A 914 GLU A 948 1 35 HELIX 11 AB2 GLU A 948 LYS A 953 1 6 HELIX 12 AB3 PRO A 957 SER A 973 1 17 HELIX 13 AB4 VAL B 739 ILE B 745 1 7 HELIX 14 AB5 THR B 761 VAL B 786 1 26 HELIX 15 AB6 GLY B 789 LEU B 793 5 5 HELIX 16 AB7 PRO B 794 SER B 805 1 12 HELIX 17 AB8 SER B 805 ASN B 823 1 19 HELIX 18 AB9 ASN B 836 ALA B 844 1 9 HELIX 19 AC1 MET B 845 GLN B 863 1 19 HELIX 20 AC2 THR B 865 LEU B 878 1 14 HELIX 21 AC3 SER B 888 VAL B 907 1 20 HELIX 22 AC4 TRP B 918 GLU B 948 1 31 HELIX 23 AC5 GLU B 948 LYS B 953 1 6 HELIX 24 AC6 PRO B 957 SER B 973 1 17 HELIX 25 AC7 VAL C 739 ILE C 745 1 7 HELIX 26 AC8 THR C 761 VAL C 786 1 26 HELIX 27 AC9 GLY C 789 LEU C 793 5 5 HELIX 28 AD1 PRO C 794 ASN C 823 1 30 HELIX 29 AD2 ASN C 836 SER C 843 1 8 HELIX 30 AD3 MET C 845 GLN C 863 1 19 HELIX 31 AD4 THR C 865 LEU C 878 1 14 HELIX 32 AD5 SER C 888 VAL C 907 1 20 HELIX 33 AD6 TRP C 918 GLU C 948 1 31 HELIX 34 AD7 GLU C 948 LYS C 953 1 6 HELIX 35 AD8 PRO C 957 VAL C 971 1 15 SHEET 1 AA1 2 LEU A 827 ALA A 830 0 SHEET 2 AA1 2 LEU A 833 PHE A 835 -1 O PHE A 835 N LEU A 827 SHEET 1 AA2 2 THR A 880 PRO A 882 0 SHEET 2 AA2 2 ALA A 976 PRO A 978 -1 O LYS A 977 N ILE A 881 SHEET 1 AA3 2 LEU B 827 ALA B 830 0 SHEET 2 AA3 2 LEU B 833 PHE B 835 -1 O PHE B 835 N LEU B 827 SHEET 1 AA4 2 THR B 880 ILE B 881 0 SHEET 2 AA4 2 LYS B 977 PRO B 978 -1 O LYS B 977 N ILE B 881 SHEET 1 AA5 2 LEU C 827 ALA C 830 0 SHEET 2 AA5 2 LEU C 833 PHE C 835 -1 O PHE C 835 N LEU C 827 SHEET 1 AA6 2 THR C 880 ILE C 881 0 SHEET 2 AA6 2 LYS C 977 PRO C 978 -1 O LYS C 977 N ILE C 881 SSBOND 1 MET A 740 MET A 959 1555 2555 2.06 SITE 1 AC1 14 LEU A 769 ASN A 770 GLN A 776 MET A 807 SITE 2 AC1 14 SER A 810 SER A 811 LEU A 814 ARG A 817 SITE 3 AC1 14 LEU A 938 PHE A 941 CYS A 942 THR A 945 SITE 4 AC1 14 VAL A 954 PHE A 956 SITE 1 AC2 14 LEU B 769 ASN B 770 GLN B 776 MET B 807 SITE 2 AC2 14 SER B 810 SER B 811 LEU B 814 ARG B 817 SITE 3 AC2 14 PHE B 829 MET B 845 LEU B 938 PHE B 941 SITE 4 AC2 14 CYS B 942 THR B 945 SITE 1 AC3 1 ARG B 817 SITE 1 AC4 15 LEU C 769 ASN C 770 LEU C 772 GLN C 776 SITE 2 AC4 15 MET C 807 SER C 810 SER C 811 LEU C 814 SITE 3 AC4 15 ARG C 817 MET C 845 LEU C 938 PHE C 941 SITE 4 AC4 15 CYS C 942 THR C 945 PHE C 956 CRYST1 121.501 121.501 44.406 90.00 90.00 120.00 P 31 9 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008230 0.004752 0.000000 0.00000 SCALE2 0.000000 0.009504 0.000000 0.00000 SCALE3 0.000000 0.000000 0.022519 0.00000